Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma, Uveal Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT00406120
What this trial is testing

Validation of a Molecular Prognostic Test for Eye Melanoma

Who this might be right for
Uveal NeoplasmsChoroid NeoplasmsIris Neoplasms
Washington University School of Medicine
Testing effectiveness (Phase 2)Looking for participantsNCT06121180
What this trial is testing

Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal Melanoma
H. Lee Moffitt Cancer Center and Research Institute 32
Not applicableStudy completedNCT01334008
What this trial is testing

Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma

Who this might be right for
Choroidal Melanoma, Diffuse
Institut Curie 40
Not applicableStudy completedNCT00351728
What this trial is testing

Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone

Who this might be right for
Ocular MelanomaChoroidal MelanomaUveal Melanoma
Jonsson Comprehensive Cancer Center 174
Testing effectiveness (Phase 2)Study completedNCT01143402
What this trial is testing

Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye

Who this might be right for
Iris MelanomaMedium/Large Size Posterior Uveal MelanomaOcular Melanoma With Extraocular Extension+3 more
National Cancer Institute (NCI) 120
Not applicableLooking for participantsNCT07364474
What this trial is testing

Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver

Who this might be right for
Uveal Melanoma
Massachusetts General Hospital 10
Testing effectiveness (Phase 2)Study completedNCT00243061
What this trial is testing

AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma

Who this might be right for
Acral Lentiginous Malignant MelanomaCiliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small Size+8 more
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT04812470
What this trial is testing

Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases

Who this might be right for
Metastatic Uveal MelanomaMetastatic Cutaneous Melanoma
Vastra Gotaland Region 8
Large-scale testing (Phase 3)Active Not RecruitingNCT05022901
What this trial is testing

An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma

Who this might be right for
Metastatic Ocular MelanomaMetastatic Uveal Melanoma
Delcath Systems Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Early research (Phase 1)Looking for participantsNCT04119024
What this trial is testing

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more
Anusha Kalbasi 18
Testing effectiveness (Phase 2)Study completedNCT02626962
What this trial is testing

Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma
Grupo Español Multidisciplinar de Melanoma 52
Testing effectiveness (Phase 2)Study completedNCT04552223
What this trial is testing

Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal Melanoma
Jose Lutzky, MD 27
Testing effectiveness (Phase 2)Study completedNCT00334776
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Southern California 6
Testing effectiveness (Phase 2)WithdrawnNCT05482074
What this trial is testing

Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2

Who this might be right for
Recurrent Metastatic MelanomaCutaneous MelanomaMucosal Melanoma+1 more
Dana-Farber Cancer Institute
Not applicableStudy completedNCT02849145
What this trial is testing

Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)

Who this might be right for
Uveal Melanoma
Institut Curie 60
Testing effectiveness (Phase 2)Looking for participantsNCT07276386
What this trial is testing

Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal Melanoma
H. Lee Moffitt Cancer Center and Research Institute 18
Not applicableStudy completedNCT04118062
What this trial is testing

Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)

Who this might be right for
Metastatic Uveal MelanomaTriple Negative Breast CancerLuminal B Breast Cancer+1 more
Institut Curie 128
Testing effectiveness (Phase 2)Study completedNCT05542342
What this trial is testing

Sitravatinib and Tislelizumab in Patients With Metastatic Uveal Melanoma With Liver Metastases.

Who this might be right for
Uveal Melanoma With Liver Metastases
Grupo Español Multidisciplinar de Melanoma 16
Testing effectiveness (Phase 2)Ended earlyNCT03417739
What this trial is testing

A Phase II Study of BVD-523 in Metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma
Dana-Farber Cancer Institute 13
Next Page